Candel Therapeutics, Inc. Cash Flow Statement

Cash Flow Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -13.70M-25.78M-35.21M-33.72M-30.20M
Depreciation and Depletion 0.80M1.00M1.00M
Share-based Compensation 2.11M2.96M2.31M3.09M5.31M
Gains from Investment Securities 4.01M4.78M5.65M-0.97M20.80M
Asset Writedowns and Impairment 0.39M0.04M
Non-cash Items 13.82M26.39M0.88M
Cash from Operations -9.07M-22.22M-31.42M-34.24M-27.02M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) 0.09M0.23M0.78M1.00M1.00M
Change in Working Capital
Change in Account Payables 0.29M0.67M-1.21M0.04M-0.18M
Change in Accured Expenses 1.51M0.30M1.26M-0.30M0.76M
Investing Activities
Capital Expenditures 1.48M1.83M1.30M0.46M0.02M
Sales of Property, Plant and Equipment 0.18M
Change in Acquisitions & Divestments 39.94M
Cash from Investing Activities 38.45M-1.83M-1.30M-0.28M-0.02M
Financing Activities
Other financing activities 0.12M
Debt Issuance and Repayment
Long-Term Debt Issuances 19.91M
Long-Term Debt Repayments -9.17M
Change in Capital Stock
Shares Issued 0.03M71.33M0.06M1.69M
Misc.
Cash from Financing Activities 0.49M71.80M19.97M-0.12M94.28M
Change in Cash 29.87M47.75M-12.74M-34.65M67.24M
Free Cash Flow -10.55M-24.05M-32.72M-34.70M-27.04M
Net Cash Flow 29.87M47.75M-12.74M-34.65M67.24M